The Protective Effect of SRI 63-441 on Ischemic Liver Injury Using the Isolated Perfused Rat Liver: Combined Protocol With Superoxide Dismutase. by Ontell, SJ et al.
The Protective bffe~t of SRI 63-441 on Ischemic Liver 
Injury Using the Isolated Perfused Rat Liver: 
Combined Protocol With Superoxide Dismutase 
S.J. Ontell. L. Makowka. V. Mazzaferro. J. Trager. P. Ove. and T.E. Starzl 
PREVENTION or reduction of ischemia/ 
reperfusion injury would be of great ben-
efit in organ transplantation. Here we briefly 
report preliminary studies evaluating a com-
bined protocol using SRI 63-441 (Sandoz 
Pharmaceuticals. Raritan. NJ), a potent 
platelet-activating factor receptor antago-
nist. 1 and superoxide dismutase (SOD), an 
oxygen free radical.scavenger, in an attempt 
to reduce ischemic injury to the liver. 
MATERIALS AND METHODS 
Male Lewis rats (250 to 300 g) were used as liver 
donors. and retired breeders were used as blood donors. 
Methoxyflurane-anesthetized rats received 300 U of hep-
arin intravenously (IV) five minutes prior to cannulation 
of the bile duct and induction of total hepatic ischemia. 
After 90 minutes of ischemia. the portal vein was cannu· 
lated and the liver harvested. Group 1. no drug treatment 
(N - 11); group ~ 12 mg/kg of SOD was added to the 
flush at harvest and 8 mg/kg of SOD was added to the 
perfusate at zero. five. and ten minutes of perfusion 
(N - 4); group 3. rats received 12 mg/kg of SOD IV at 
the time of hep';rinization and 12 mg/kg of SOD was 
added 10 the flush at harvest (N - 4); group 4. rats 
received 12 mgt kg of SOD IV at the time of hep8'riniza. 
lion. 12 mg/kg SOD was added to the flush at harvest. 
and 8 mg/kg of SOD was added to the perfusate at zero. 
five. and ten minutes of perfusion (N - 4); group 5. rats 
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received 20 mg/kg of SRI 63-441 at the time of heparini. 
zation. 6.5 mg/kl of SOD was added to the ftusb at 
harvest. and 6.S mg/kg of SOD wu added to the per-
fusate at zero minutes of perfusion (N - 6), Upon har-
vest. the liver was Hushed with 60 mL cooled, heparinized 
(10 U/mL) Ringer's lactate solution (4"C). placed on a 
perfusion apparatus.2 and perfused with a warm. oxygen-
ated (p02' 500 torr). dilute sanguinous (het. 2S; diluent. 
Krebs bicarbonate buffer) solution at J7oe. pH 7.4 for 90 
minutes. Bile production and perfusate SOOT ancl SGPT 
levels were measured every 30 minutes. Results are 
expressed as mean :t SEM and compared using an 
independent Student's, test, 
RESULTS 
The three groups using SOD alone (groups 
2, ~ and. 4) all show an increase in bile 
production and a decrease in perfusate trans-
aminases when compared to controls (group 
I) (Table I). Only in group 2 was a significant 
difference seen in all three parameters mea-
sured (P < .05), There was a significant 
increase in bile production in group 5 com-
pared to group I (P < ,005); however. there 
was no significant difference between trans-
aminase levels of the two groups. 
DISCUSSION AND CONCLUSIONS 
It has recently been suggested that platelet 
activating factor (PAF) may be a central 
mediator of the microcirculatory failure that 
ensues following ischemic organ injury. PAF 
is released from a number of cells and plays a 
significant role in almost every aspect of the 
inflammatory response.J SRI 63-441 is the 
most potent PAF receptor antagonist devel-
oped to date. In our previous study, there was 
a significant increase in bile production and 
decrease in perfusate transaminases in ani-
mals pretreated with 20 mg/kg of SRI 63-441 
prior to induction of ischemia compared with 
controls: It was anticipated that the addition 
of a second agent. which acted throqh a 
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Table 1. Effect of SRI ~1 and SOD on Pa,.metera of Hepetlc Function 
Group. N r ..... lmin. poriueianl Bile Iml.l SGPTUUI SGOTUUI 
11 30 0.00 ± 0.00 1.074 ± 99 1.006 ± 103 
60 0.03 ± 0.01 1.274 ± 108 1.166 ± 120 
90 0.07 ± 0.02 1.390 ± 99 1.319 ± 119 
2 4 30 0.03 ± 0.03 424 ± 67 474:!: 120 
60 0.11 :!: 0.05 488 ± 93 562 ± 140 
90 0.19 ± 0.08 673 :!: 202 , 721 ± 184 ' 
3 4 30 0.06 ± 0.03 " 678±216 809 ± 206 
60 0.09 ± 0.03 868 ± 208 990 ± 204 , 
90 0.13 ± 0.03 1.048 ± 181. 1.184±214 
4 4 30 0.06 :!: 0.02 402 ± 78 604 ± 137 
60 0.09 ± 0.04 434 ± 146 686 ± 137 
90 0.11 :!: 0.06 671 ± 130 , 866 ± 178 • 
5 6 30 0.04 ± 0.01 989 ± 122 952 ± 92 
60 0.12 ± 0.04 1.068 ± 116 1.128 ± 103 
90 0.23:!: 0.06 1.097 ± 134 1.248 ± 106 
NOTE. All VIIUM expressed ere X :!: SEM. Significance: P < .05 group 2 v group 1 III paramet ... ; P < .005 group 5 v group 
1 bile production only . 
• Groups: 1. control; 2. SOD 12 mg/kg flush Ind 8 mg/kg x 3 perfusate; 3. SOD 12 mg/kg pretreatment Ind 12 mg/kg 
flush; 4. SOD 12 mg/kg pretrntment. 12 mg/kg flush and 8 mg/kg x 3 perfuaate; 5. SRI 63-441 20 mg/kg pre1rle1ment + 
SOD 6.5 mg/kg flush and 6.5 mg/kg perfusate. 
different mechanism, might further improve 
postischemic hepatic function. SOD has been 
shown to be protective in kidneys subjected to 
warm ischemia.s The decision to add SOD 
was based on the preliminary results in groups 
2, 3, and 4. A lesser dose of SOD was added in 
the combined study because earlier experi-
ments (not reported) at the higher dosage did 
not show an increase in bile production and 
there was some concern of toxicity. The pre-
liminary studies with SOD indicated that, as 
expected, SOD must be present at the time of 
reperfusion to exert a beneficial effect. The 
addition of SOD to SRI 63-441 pretreatment 
did not result in an improvement over SRI 
63-441 pretreatment alone. In fact, at this 
time, the results are equivocal with an 
improvement in bile production, but none in 
perfusate transaminases. The complexity and 
multiplicity of cascades involved in the media-
tion of ischemia/reperfusion injury make it 
highly likely that effective pharmacologic 
modulation of the injury, leading to prolonga-
tion of organ preservation. will involve a poly-
pharmacy approach. The ultimate "cocktail" 
would contain several agents that act at dif-
ferent critical points along the multiple path-
ways. It is not unexpected, as in the study 
reported here, that agents anticipated to 
behave synergistically could upset the fine 
balance in the cell's homeostatic mechanisms 
and invoke a detrimental response. 
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